Leishmaniasis East Africa Platform (LEAP)
Founded: 2003, Khartoum, Sudan
The LEAP platform aims to strengthen clinical research capacity, which is lacking in part due to the remoteness and geographic spread of the patients, most of whom live in the most impoverished regions of Africa. The platform also is a base for ongoing educational cooperation between the countries in the East African region and standardization of procedures and practices within the region, as far as is possible within the confines of local regulations. LEAP evaluates, validates, and registers new treatments that address regional needs for visceral leishmaniasis.
‘I am proud to be a part of a team that gained new knowledge through training and participation in a clinical trial for the first time.’
The Platform is active in:
- Treatments & access
- Clinical trials
- Capacity strengthening
- The 22nd LEAP meeting took place in Khartoum, Sudan in October 2015, with 68 participants, alongside the 22nd LEAP Principal Investigators (PIs) Meeting and the 1st Project Advisory Committee (PAC) of the AfriCoLeish Project
- “New combination treatments for VL in Africa” and Fexinidazole studies were completed.
- 1st LEAP Conference & 21st LEAP Meeting: 29 September – 2 October, 2014